Status:
COMPLETED
Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Immature Arteriovenous Fistula
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Arteriovenous fistulas (AVFs) are the preferred type of vascular access for dialysis, but many of them fail to mature. The optimal timing of intervention to salvage immature AVFs is unknown.The study ...
Detailed Description
The optimal timing of intervention in non-maturing AVFs remains controversial, and can only be definitively addressed by a randomized clinical trial (RCT) comparing early (6 weeks) vs late (3 months) ...
Eligibility Criteria
Inclusion
- Patients with End stage renal disease (ESRD).
- Patients on hemodialysis.
- Patients using central venous catheter (CVC).
- Patients who had a new AVF created after commencing dialysis.
- Patients who had immature fistula ( 6-week postoperative ultrasound that revealed an immature AVF (diameter \< 4 mm diameter or blood flow \< 500 ml/min).
Exclusion
- • Children with Age below 18
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03245944
Start Date
March 1 2018
End Date
March 1 2020
Last Update
April 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UAB
Birmingham, Alabama, United States, 35201